{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0017582/ORPHA:300385","label":"Pituitary carcinoma","mondoId":"MONDO:0017582","onsetQualifier":null,"recordKeys":["007b6d22db0babc7283d04469ef5800ce27ea05b11e0c52b584b64da5812e970","01a22f89640612b3a85502c0597bfa19a51e7968550b753e1702db275a7e35ed","0c1db80c4b36cc92c4deb885268eff14f38a06e36f8681aa064fd478bc0f97c5","0e0067164dee313b9d59bfdd8a5b075c6548601a578ffca86d7cd38ab79f8d82","24e32a9fdd0b35f86a332915b96cc302551543067114ab825e2fefe09d2d53b4","261859ddad27b482cec09f0273454a13f16181083e023e758fcf499778c65ae1","2e5bc3f44d0e1c9336cab466c923b62c7cbe0cee4457f98ea8da0380c04dcf4b","31595492cf89802bd09545fa17e6ef6db4215f02a6cd4931f5b3bf69ef44451a","3fbced09215762620f08947f9f9749b0f7d8c6492707e026acaff2b1ce0bb1d7","477e8bb0c26565eb7947cd36d31f766b1aac491d7be56e140ce9a81954e48821","4aa006c9b0f3ddcab4584398383c0ced2281de61e53e3b06be4cbed9f21bd805","5444bd2d5c3540a3f8d4b85007b3ccccf6c5ad35ef970ee27250371cd6f04fbd","5c770c2a551ff38aaf432873d4470ffb2b81261c1d51e851ea937a51b143d228","7086059cb5ec3490f2bb01a8ee74b06cfb4889f94e31aad15266a23df684752c","96dfda6c245b9b65cd20c917059b7b3432792ee1cef236082ca1bc03d720be0b","97016764bcf9e0311c0cfc79b3300b439458c57d331411da05a1c5c3edbe501b","9ec745100d376a96b9929845897ced0ebf20d9ac0e6947d9bda3dba76f4d7b76","a3f31e3b0fb52e2a3064c4291ef3b7fac916bd12fc2c319d8303375cbe93956f","a54d11a7e4dff0beb8f91043f14fda936c9154d36319faaf9df89cd91d4b4434","b9243687ba6ff8421e24f9eecd5151b40def475d400d6a0a11f4fac9d3034259","ebe3d0f072d4782af279db139540b3155c40dc228b176e27d9f1d37828a1b1a9","edf196db85324929d440eb28fe31253fc7a8530062140a64b194e19160273292"],"recordQualifiers":{},"scopeLabel":"ORPHA:300385","sourceIds":["ORPHA:300385"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0017582/ORPHA:300385"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":22,"sourceGroups":{"omim":0,"orphanet":22,"published":0}},"features":[{"hpoId":"HP:0011442","label":"Abnormal central motor function","primary":false},{"hpoId":"HP:0001251","label":"Ataxia (coordination difficulty)","primary":false},{"hpoId":"HP:0000873","label":"Diabetes insipidus","primary":false},{"hpoId":"HP:0000845","label":"Elevated circulating growth hormone concentration","primary":false},{"hpoId":"HP:0012505","label":"Enlarged pituitary gland","primary":false},{"hpoId":"HP:0002315","label":"Headache","primary":false},{"hpoId":"HP:0000365","label":"Hearing loss","primary":false},{"hpoId":"HP:0012377","label":"Hemianopia","primary":false},{"hpoId":"HP:0010514","label":"Hyperpituitarism","primary":false},{"hpoId":"HP:0040075","label":"Hypopituitarism","primary":false},{"hpoId":"HP:0003154","label":"Increased circulating ACTH level","primary":false},{"hpoId":"HP:0000870","label":"Increased circulating prolactin concentration","primary":false},{"hpoId":"HP:0100836","label":"Malignant neoplasm of the central nervous system","primary":false},{"hpoId":"HP:0011763","label":"Pituitary carcinoma","primary":false},{"hpoId":"HP:0008291","label":"Pituitary corticotropic cell adenoma","primary":false},{"hpoId":"HP:0011759","label":"Pituitary gonadotropic cell adenoma","primary":false},{"hpoId":"HP:0011760","label":"Pituitary growth hormone cell adenoma","primary":false},{"hpoId":"HP:0006767","label":"Pituitary prolactin cell adenoma","primary":false},{"hpoId":"HP:0011762","label":"Pituitary thyrotropic cell adenoma","primary":false},{"hpoId":"HP:0007987","label":"Progressive visual field defects","primary":false},{"hpoId":"HP:0007663","label":"Reduced visual acuity","primary":false},{"hpoId":"HP:0100561","label":"Spinal cord lesion","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0017582","records":[{"frequencyKind":"range","key":"007b6d22db0babc7283d04469ef5800ce27ea05b11e0c52b584b64da5812e970","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"01a22f89640612b3a85502c0597bfa19a51e7968550b753e1702db275a7e35ed","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012377","is_excluded":false,"label":"Hemianopia","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0c1db80c4b36cc92c4deb885268eff14f38a06e36f8681aa064fd478bc0f97c5","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008291","is_excluded":false,"label":"Pituitary corticotropic cell adenoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0e0067164dee313b9d59bfdd8a5b075c6548601a578ffca86d7cd38ab79f8d82","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0006767","is_excluded":false,"label":"Pituitary prolactin cell adenoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"24e32a9fdd0b35f86a332915b96cc302551543067114ab825e2fefe09d2d53b4","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000873","is_excluded":false,"label":"Diabetes insipidus","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"261859ddad27b482cec09f0273454a13f16181083e023e758fcf499778c65ae1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2e5bc3f44d0e1c9336cab466c923b62c7cbe0cee4457f98ea8da0380c04dcf4b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"31595492cf89802bd09545fa17e6ef6db4215f02a6cd4931f5b3bf69ef44451a","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0040075","is_excluded":false,"label":"Hypopituitarism","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3fbced09215762620f08947f9f9749b0f7d8c6492707e026acaff2b1ce0bb1d7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100561","is_excluded":false,"label":"Spinal cord lesion","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"477e8bb0c26565eb7947cd36d31f766b1aac491d7be56e140ce9a81954e48821","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002315","is_excluded":false,"label":"Headache","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4aa006c9b0f3ddcab4584398383c0ced2281de61e53e3b06be4cbed9f21bd805","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100836","is_excluded":false,"label":"Malignant neoplasm of the central nervous system","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5444bd2d5c3540a3f8d4b85007b3ccccf6c5ad35ef970ee27250371cd6f04fbd","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011760","is_excluded":false,"label":"Pituitary growth hormone cell adenoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c770c2a551ff38aaf432873d4470ffb2b81261c1d51e851ea937a51b143d228","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0011759","is_excluded":false,"label":"Pituitary gonadotropic cell adenoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7086059cb5ec3490f2bb01a8ee74b06cfb4889f94e31aad15266a23df684752c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012505","is_excluded":false,"label":"Enlarged pituitary gland","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"96dfda6c245b9b65cd20c917059b7b3432792ee1cef236082ca1bc03d720be0b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007987","is_excluded":false,"label":"Progressive visual field defects","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"97016764bcf9e0311c0cfc79b3300b439458c57d331411da05a1c5c3edbe501b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003154","is_excluded":false,"label":"Increased circulating ACTH level","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9ec745100d376a96b9929845897ced0ebf20d9ac0e6947d9bda3dba76f4d7b76","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000845","is_excluded":false,"label":"Elevated circulating growth hormone concentration","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a3f31e3b0fb52e2a3064c4291ef3b7fac916bd12fc2c319d8303375cbe93956f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011442","is_excluded":false,"label":"Abnormal central motor function","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a54d11a7e4dff0beb8f91043f14fda936c9154d36319faaf9df89cd91d4b4434","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0011763","is_excluded":false,"label":"Pituitary carcinoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b9243687ba6ff8421e24f9eecd5151b40def475d400d6a0a11f4fac9d3034259","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000870","is_excluded":false,"label":"Increased circulating prolactin concentration","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ebe3d0f072d4782af279db139540b3155c40dc228b176e27d9f1d37828a1b1a9","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010514","is_excluded":false,"label":"Hyperpituitarism","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"edf196db85324929d440eb28fe31253fc7a8530062140a64b194e19160273292","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0011762","is_excluded":false,"label":"Pituitary thyrotropic cell adenoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"pituitary-adenocarcinoma","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"pituitary adenocarcinoma"},"schemaVersion":1}